Clinical trials on efficacy and safety of 3 novel combinations of Nobiletin, Kaempferia parviflora and Peucedanum japonicum for urine storage disorder

Clinical trials on efficacy and safety of 3 novel combinations of Nobiletin, Kaempferia parviflora and Peucedanum japonicum for urine storage disorder - Clinical trials of Nobiletin, Kaempferia parviflora and Peucedanum japonicum for urine storage disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035619

Enrollment

Registered

2019-01-22

Start date

2019-01-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urine storage disorders (urinary frequency, nocturia, urinary urgency, urgency incontinence)

Interventions

Using 600 mg of 3 capsules (600 mg of content: Nobiletin high purity (60%) Seikwasa extract, Novilex 55 mg + Kaempferia parviflora dry powder 388 mg + Peucedanum japonicum dry powder 100 mg + crystall

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: urine storage disorders (urinary frequency, nocturia, urinary urgency, urgency incontinence) have been present for more than 2 months but untreated adults

Exclusion criteria

Exclusion criteria: 1.Those who are being treated for dysuria 2.Within two months of termination of treatment of voiding disorder 3.Those with no urinary trust 4.Difficulty of urination is the main symptom 5.Those with difficult communication difficulties

Design outcomes

Primary

Measure	Time frame
overactive bladder symptom score	—

Secondary

Measure	Time frame
International prostate symptom score and QOL score	—

Countries

Japan

Contacts

Public ContactKimio Sugaya

Kitakami Central Hospital. Department of Urology Director

sugaya@medu-ryukyu.ac.jp098-936-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026